These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6079588)

  • 41. [No. 207. Elementary prescriptions for therapy of arteriosclerosis].
    Meccoli V; Fanelli V
    Clin Ter; 1968 Dec; 47(5):523-8. PubMed ID: 5706854
    [No Abstract]   [Full Text] [Related]  

  • 42. [Role of arteriosclerosis in the development of an acute disorder of the mesenteric circulation].
    Gagarin VV
    Vestn Khir Im I I Grek; 1984 Oct; 133(10):52-6. PubMed ID: 6516159
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Use of anabolic steroids in postinfarct cardiosclerosis].
    Baturina TS; Bondarenko IP; Vlasenko LI; Dubinskiĭ AA; Meĭtin IIa
    Vrach Delo; 1982 Apr; (4):49-52. PubMed ID: 7101857
    [No Abstract]   [Full Text] [Related]  

  • 44. Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women.
    Simon J; Klaiber E; Wiita B; Bowen A; Yang HM
    Menopause; 1999; 6(2):138-46. PubMed ID: 10374221
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of pioglitazone on arteriosclerosis in comparison with that of glibenclamide.
    Watanabe I; Tani S; Anazawa T; Kushiro T; Kanmatsuse K
    Diabetes Res Clin Pract; 2005 May; 68(2):104-10. PubMed ID: 15860237
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transdermal testosterone gel (Cellegy).
    McGriff-Lee NJ
    Curr Opin Investig Drugs; 2002 Nov; 3(11):1629-32. PubMed ID: 12476964
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The skin as chief manifestation. Is it really an allergy?].
    Holzgreve H
    MMW Fortschr Med; 2004 Mar; 146(10):47-8. PubMed ID: 15347089
    [No Abstract]   [Full Text] [Related]  

  • 48. [Dicinon in the treatment of arteriosclerotic macular dystrophy].
    Korneva TS
    Oftalmol Zh; 1980; 35(5):300-2. PubMed ID: 7422220
    [No Abstract]   [Full Text] [Related]  

  • 49. [L-arginine. A key substance for dietetic therapy in arteriosclerosis?].
    Wingler K; Schmidt H
    Med Monatsschr Pharm; 2005 Mar; 28(3):97-103. PubMed ID: 15794368
    [No Abstract]   [Full Text] [Related]  

  • 50. Effect of lifestyle and/or statin treatment on soluble markers of atherosclerosis in hypertensives.
    Hjelstuen A; Anderssen SA; Holme I; Seljeflot I; Klemsdal TO
    Scand Cardiovasc J; 2007 Oct; 41(5):313-20. PubMed ID: 17852781
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Hereditary angioneurotic edema (author's transl)].
    Löhle E; Mann W
    HNO; 1980; 28(9):305-7. PubMed ID: 7462039
    [TBL] [Abstract][Full Text] [Related]  

  • 52. "Risk factors" and manifestations of arteriosclerosis in patients with intermittent claudication compared to normal persons.
    Jacobsen UK; Dige-Pedersen H; Gyntelberg F; Svendsen UG
    Dan Med Bull; 1984 Apr; 31(2):145-8. PubMed ID: 6723377
    [No Abstract]   [Full Text] [Related]  

  • 53. [Pharmacologic therapy of arteriosclerosis: current possibilities].
    Priego JG; Díaz Méndez M
    Med Clin (Barc); 1984 Oct; 83(10):431-2. PubMed ID: 6503408
    [No Abstract]   [Full Text] [Related]  

  • 54. [Treatment of arteriosclerotic peripheral vascular diseases with ciclonicate].
    Gregoratti L; Crespi B; Groothold G; Fuligni E; Ghiringhelli L
    Minerva Cardioangiol; 1982 Nov; 30(11):659-68. PubMed ID: 7155375
    [No Abstract]   [Full Text] [Related]  

  • 55. Tracking regression and progression of atherosclerosis in human carotid arteries using high-resolution magnetic resonance imaging.
    Adams GJ; Greene J; Vick GW; Harrist R; Kimball KT; Karmonik C; Ballantyne CM; Insull W; Morrisett JD
    Magn Reson Imaging; 2004 Nov; 22(9):1249-58. PubMed ID: 15607096
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Prevention of arteriosclerosis from the very beginning. Therapy with specific synergistic vitamins against hyperhomocysteinemia].
    Fortschr Med Suppl; 1993; 145():1-19. PubMed ID: 8406287
    [No Abstract]   [Full Text] [Related]  

  • 57. Treatment with L-arginine is likely to stimulate generation of nitric oxide in patients with peripheral arterial obstructive disease.
    Gryglewski RJ; Grodzińska L; Kostka-Trabka E; Korbut R; Bieroón K; Goszcz A; Sławiński M
    Wien Klin Wochenschr; 1996; 108(4):111-6. PubMed ID: 8867484
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [ERG and EOG in arteriosclerotic disease of the macula].
    Hrachovina V; Haklová M
    Cesk Oftalmol; 1983 Sep; 39(5):317-20. PubMed ID: 6640693
    [No Abstract]   [Full Text] [Related]  

  • 59. [Treatment of hyperdyslipidemia in chronic atherosclerotic peripheral obliterating arteriopathies of the lower limbs].
    Bagliani A; Argenteri A; La Rosa A
    Clin Ter; 1982 Dec; 103(6):647-61. PubMed ID: 7160147
    [No Abstract]   [Full Text] [Related]  

  • 60. [Peripheral vasculopathies and some metabolic disorders in the aged. Effectiveness of xanthinol-nicotinate therapy].
    Martinelli V; Montori A; Cappelletti F
    G Gerontol; 1970 Jul; 18(7):661-7. PubMed ID: 5533446
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.